4//SEC Filing
Kwietniak Matthew R. 4
Accession 0001683168-24-007161
CIK 0000704562other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:40 PM ET
Size
9.9 KB
Accession
0001683168-24-007161
Insider Transaction Report
Form 4
Kwietniak Matthew R.
Chief Commercial Officer
Transactions
- Sale
Common Stock, $0.001 par value
2024-10-14$10.15/sh−119$1,208→ 25,407 total - Exercise/Conversion
Restricted Stock Units
2024-10-11−335→ 75,112 total→ Common Stock (335 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2024-10-11+335→ 25,526 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the vesting and release of the RSUs described in footnote 4. This sale does not represent a discretionary trade by the reporting person.
- [F3]Represents a weighted average sales price per share. These shares were sold at prices ranging from $10.15 to $10.16. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]RSUs granted to the reporting person on October 11, 2021, is subject to a four (4) year vesting schedule. 25% vested on the first anniversary of the date of grant, and the remaining balance vest in twelve (12) equal quarterly installments beginning January 11, 2023 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
Documents
Issuer
Avid Bioservices, Inc.
CIK 0000704562
Entity typeother
Related Parties
1- filerCIK 0001974519
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 7:40 PM ET
- Size
- 9.9 KB